tradingkey.logo

Belite Bio Inc <BLTE.OQ> expected to post a loss of 37 cents a share - Earnings Preview

ReutersMay 12, 2025 8:04 PM
  • Belite Bio Inc BLTE.OQ BLTE.O is expected to show no change in quarterly revenue when it reports results on May 14 for the period ending March 31 2025

  • ​LSEG's mean analyst estimate for Belite Bio Inc is for a loss of 37 cents per share.

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 5 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

  • The mean earnings estimate of analysts was unchanged in the last three months. ​

  • Wall Street's median 12-month price target for Belite Bio Inc is $90.00​, above​ its last closing price of $61.10. ​​​

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING

STARMINESMARTESTIMATE®

LSEG IBES ESTIMATE

ACTUAL

BEAT, MET, MISSED

SURPRISE %

Dec. 31 2024

-0.29

-0.31

-0.32

Missed

-4

Sep. 30 2024

-0.29

-0.29

-0.28

Beat

2.8

Jun. 30 2024

-0.27

-0.25

-0.31

Missed

-22.7​

Mar. 31 2024

-0.31

-0.28

-0.27

Beat

4.9

​​Dec. 31 2023

-0.33

-0.30

-0.25

Beat

16.7

Sep. 30 2023

-0.36

-0.32

-0.40

Missed

-24.8​

Jun. 30 2023

-0.40

-0.30

-0.26

Beat

12.6

Mar. 31 2023

-0.17

-0.20

-0.33

Missed

-65

This summary was machine generated May 12 at 20:04 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI